A detailed history of State Board Of Administration Of Florida Retirement System transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 23,870 shares of BEAM stock, worth $574,073. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,870
Previous 23,870 -0.0%
Holding current value
$574,073
Previous $559,000 4.47%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$21.22 - $32.66 $83,819 - $129,006
3,950 Added 19.83%
23,870 $559,000
Q1 2024

May 08, 2024

BUY
$23.46 - $45.07 $234 - $450
10 Added 0.05%
19,920 $658,000
Q3 2023

Nov 08, 2023

BUY
$23.01 - $32.46 $11,735 - $16,554
510 Added 2.63%
19,910 $478,000
Q2 2023

Aug 11, 2023

SELL
$29.32 - $35.99 $15,246 - $18,714
-520 Reduced 2.61%
19,400 $619,000
Q4 2022

Feb 07, 2023

SELL
$36.73 - $51.6 $40,770 - $57,276
-1,110 Reduced 5.28%
19,920 $779,000
Q3 2022

Nov 08, 2022

SELL
$39.79 - $70.31 $177,065 - $312,879
-4,450 Reduced 17.46%
21,030 $1 Million
Q2 2022

Aug 05, 2022

BUY
$29.86 - $62.36 $161,244 - $336,744
5,400 Added 26.89%
25,480 $986,000
Q4 2021

Feb 08, 2022

SELL
$68.02 - $99.06 $33,125 - $48,242
-487 Reduced 2.37%
20,080 $1.6 Million
Q3 2021

Nov 08, 2021

BUY
$84.37 - $133.6 $16,030 - $25,384
190 Added 0.93%
20,567 $1.79 Million
Q2 2021

Aug 10, 2021

BUY
$64.12 - $128.71 $354,711 - $712,023
5,532 Added 37.27%
20,377 $2.62 Million
Q1 2021

May 10, 2021

BUY
$71.28 - $120.75 $2,851 - $4,830
40 Added 0.27%
14,845 $1.19 Million
Q4 2020

Feb 08, 2021

BUY
$22.24 - $95.63 $329,263 - $1.42 Million
14,805 New
14,805 $1.21 Million

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.69B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.